New drug combo targets Hard-to-Treat cancers

NCT ID NCT06764771

Ongoing Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Nov 05, 2025 · Last updated May 15, 2026 · Updated 23 times

Summary

This early-stage study tests an experimental drug, BMS-986488, alone or with other treatments, in adults with advanced solid tumors that have not responded to standard therapy. The main goals are to check safety and find the right dose. About 437 participants with specific cancer types, like kidney or lung cancer, are involved. This is not a cure, but aims to control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Local Institution - 0015

Montreal, Quebec, H2X 0A9, Canada
Local Institution - 0016

Québec, Quebec, G1J 1Z4, Canada
Local Institution - 0020

Allentown, Pennsylvania, 18103, United States
Local Institution - 0021

Hackensack, New Jersey, 07601, United States
Local Institution - 0024

Germantown, Tennessee, 38138, United States
Local Institution - 0031

Brisbane, Queensland, 4029, Australia
Local Institution - 0032

Vancouver, British Columbia, V5Z 4E6, Canada

Conditions

Explore the condition pages connected to this study.

ADVANCED MALIGNANT TUMORS